Medication info
Tracetacemiserabongjeong (Acetaminophen, Tramadol)

Tracetacemiserabongjeong (Acetaminophen, Tramadol)

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
Pale yellow round prolonged-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907323 · Approved 2019.10.17 · Insurance code 641607040

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 12 hours, without exceeding 8 tablets per day. Do not administer this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust the treatment appropriately. Elderly patients: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 12 hours, without exceeding 8 tablets per day. Do not administer this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment; monitor the patient's response closely and adjust the treatment appropriately. Elderly patients: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication may put a strain on the liver, so individuals who regularly consume more than 3 glasses of alcohol daily should consult a doctor or pharmacist before taking it. The acetaminophen included in this medication can rarely cause severe skin reactions, so if you experience a rash or hypersensitivity, you should stop taking it immediately. Taking tramadol in amounts exceeding the recommended dosage can increase the risk of seizures, and combining it with certain antidepressants or narcotics can further increase the risk of seizures. This medication can cause respiratory depression in patients with compromised respiratory function or in those with acute asthma and should only be used under medical supervision. Co-administration of this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, or coma, so caution is required. Patients with head injuries or elevated intracranial pressure may experience worsening symptoms while taking this medication, so caution in administration is needed. Tramadol has the potential for dependency or abuse; therefore, caution is necessary with long-term use, and withdrawal symptoms may occur. This medication should not be used in children under 12 years of age or in pediatric patients after certain surgeries, and dosage adjustment is required for elderly patients or those with liver or kidney impairment. Women who are pregnant or breastfeeding should consult a physician before taking this medication, as it can be transmitted to the infant. Drowsiness or dizziness may occur after taking this medication, so caution is advised when engaging in activities that require concentration, such as driving or operating machinery. Severe side effects may occur with overdose; therefore, do not exceed the prescribed dosage, and if an overdose occurs, contact a medical facility immediately for appropriate treatment. This medication can interact with various drugs; therefore, you must inform your medical provider of any other medications being taken, especially with antidepressants, opioid analgesics, and central nervous system depressants.

Side effects

Liver damage, acute generalized rash with pustules, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, fainting, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremor, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, stupor, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, confusion, euphoria, insomnia, nervous irritability, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, shortness of breath, proteinuria, urinary disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vascular relaxation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, cognitive dysfunction, difficulty concentrating, suicidal tendency, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatigued glutamic acidosis, leukoplakia, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, reduced immune response, sensory abnormalities, stupor, dysgeusia, involuntary muscle contractions, peripheral edema, pallor, blood pressure fluctuations, cough, runny nose, elevated blood pressure, palpitations, irregular menstruation, breast cancer, injury, congestive heart failure, dizziness, stupor, exertional dyspnea, bronchitis, frequent urination, abnormal kidney function levels, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, aortic stenosis, bleeding, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, cholangiocarcinoma progression, foreign body sensation in the eye, liver cancer progression, paralytic ileus, hiccups, cholecystitis, stupor, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, heartburn, unspecified gastrointestinal disorder, acute gastritis, cold, upper respiratory infection, generalized weakness, motion sickness, lethargy, weakness, fever, chest discomfort, facial swelling, drowsiness, insomnia, decreased appetite, anxiety, depression, nervous irritability, emotional instability, hallucinations, depersonalization

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Pale yellow round prolonged-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.